Results from evaluation of the company's SpliceCore® AI/ML platform in Triple Negative Breast Cancer published in Molecular Systems Biology
Envisagenics, an AI-driven biotechnology company, announced the...
Tempus, a leader in artificial intelligence and precision medicine, will present new data along with Pfizer at the AACR 2024 Annual Meeting. The abstract,...
Atomic AI’s ATOM-1 large language model (LLM) demonstrates state-of-the-art accuracy for predicting RNA structure and function
Atomic AI, a biotechnology company fusing cutting-edge machine learning...
EnginZyme AB, a deep-tech company whose cell-free biomanufacturing technology uses the power of enzymes to create sustainable products and processes for a variety of...